ATHEROSCLEROSIS REGRESS WITH THERAPY FOR LOW HDLC

低 HDLC 治疗可使动脉粥样硬化消退

• 批准号: 6113070
• 负责人: B G BROWN
• 金额: $ 0.39万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6113070
• 关键词: angiography; antioxidants; atherosclerosis; cardiovascular disorder chemotherapy; clinical research; clinical trials; coronary disorder; disease /disorder proneness /risk; drug screening /evaluation; high density lipoproteins; human subject; human therapy evaluation; remission /regression

This study is an angiographic trial designed to assess the effectiveness of lipid-altering medications, antioxidant therapy, and hygienic measures in controlling coronary atherosclerosis in patients whose primary indicator of risk is low HDLc. It will also attempt to assess the clinical consequences of these treatments for this group of patients.

本研究是一项血管造影试验，旨在评估调脂药物、抗氧化治疗和卫生措施在控制主要风险指标为低HDL c患者冠状动脉粥样硬化中的有效性。 它还将试图评估这些治疗对这组患者的临床后果。